| WHO Grade 4 Glioma studied in …STUDIED_INderived200 of 1,854show all (up to 200) |
|---|
| → studied in | NCT05685004Phase 2/Phase 3 · active not recruiting Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864534Phase 2 · active not recruiting Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05871021Phase 2 · active not recruiting Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902169Phase 3 · recruiting Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06325683Phase 2 · suspended Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303467Phase 1 · recruiting A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432804Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07145112Phase 1 · recruiting Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07326566Phase 2 · recruiting Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416188Phase 1/Phase 2 · recruiting Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896568Phase 1 · recruiting MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183204Phase 2 · completed Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195591Phase 3 · recruiting Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07422896Phase 1 · not yet recruiting A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115761Phase 2 · recruiting Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05635734Phase 1/Phase 2 · completed Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07568782not yet recruiting Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers. · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174197Phase 1/Phase 2 · completed Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729959Phase 2 · active not recruiting Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837547Phase 1 · active not recruiting PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05353530Phase 1 · active not recruiting IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389591Phase 1 · recruiting RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06558214Phase 2 · recruiting OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07515924early Phase 1 · not yet recruiting Oral Gallium Maltolate for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708961Phase 2 · suspended Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821112Phase 2 · not yet recruiting Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile® · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05109728Phase 1 · active not recruiting A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832448NA · active not recruiting Microsurgical Resection Combined With Photodynamic Therapy for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03223103Phase 1 · active not recruiting Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04977375Phase 1/Phase 2 · recruiting Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06804655Phase 2 · recruiting Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06838676Phase 2 · recruiting ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831161NA · not yet recruiting Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831187Phase 1/Phase 2 · not yet recruiting Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831369Phase 2 · recruiting VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831772NA · recruiting REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587038Phase 1 · active not recruiting OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077735Phase 2 · active not recruiting Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07089641Phase 1 · recruiting ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277638Phase 1/Phase 2 · completed Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06816927Phase 2 · recruiting Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974738Phase 1 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03535350Phase 1 · active not recruiting Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974621Phase 2 · active not recruiting Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03115333NA · active not recruiting DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05495295Phase 1 · active not recruiting First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06129760NA · suspended Glioblastoma Remote Monitoring and Care - Research Protocol · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132438Phase 1 · recruiting Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357377Phase 1 · recruiting A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389278Phase 1/Phase 2 · not yet recruiting Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704858Phase 1/Phase 2 · active not recruiting Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698524Phase 1 · recruiting A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797661NA · recruiting Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions. · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870944Phase 1/Phase 2 · recruiting CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Midline Glioma, H3 K27-Altered | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Midline Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349693Phase 2/Phase 3 · not yet recruiting Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07452458Phase 3 · recruiting Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811297Phase 1/Phase 2 · not yet recruiting A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212274Phase 2 · active not recruiting Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139056Phase 1 · recruiting Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06329570Phase 1/Phase 2 · suspended Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06410248Phase 1 · recruiting Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | WHO Grade 4 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613841early Phase 1 · recruiting Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06934889Phase 1 · recruiting Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946680Phase 1 · not yet recruiting IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG) · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989086NA · recruiting FearLess in NeuroOncology · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07644312Phase 2 · not yet recruiting Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | WHO Grade 4 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839379recruiting Targeted Pediatric High-Grade Glioma Therapy · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02981940Phase 2 · active not recruiting A Study of Abemaciclib in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03911388Phase 1 · recruiting HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991870Phase 1 · recruiting Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894225Phase 2 · recruiting Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337686Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03657576Phase 1 · completed Trial of C134 in Patients With Recurrent GBM · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04677049Phase 1/Phase 2 · active not recruiting Study of Niacin in Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465199Phase 1/Phase 2 · recruiting Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356973Phase 2 · recruiting Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07384884NA · recruiting Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04188535NA · recruiting Serial MRI Scans During Radiation Therapy · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Adult Diffuse Hemispheric Glioma, H3 G34-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161974Phase 2 · recruiting Study of Olutasidenib and Temozolomide in HGG · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180927Phase 1/Phase 2 · not yet recruiting DLL3 CAR-T Therapy Targeting Brain Tumors · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Cerebellar Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145115Phase 2 · active not recruiting A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04201873Phase 1 · completed Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796061Phase 1 · not yet recruiting Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT) · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02179086Phase 2 · active not recruiting Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04181684NA · active not recruiting LITT Followed by Hypofractionated RT for Recurrent Gliomas · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303519Phase 3 · recruiting SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07420543active not recruiting Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781852early Phase 1 · not yet recruiting Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03975829Phase 4 · active not recruiting Pediatric Long-Term Follow-up and Rollover Study · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409584recruiting Mental Health and Suicidality in Glioblastoma Patients in Germany · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501156Phase 1/Phase 2 · not yet recruiting H3K27M-specific Immune Effector Cells Targeting DMG/DIPG · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789379Phase 2 · not yet recruiting Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791264Phase 1 · not yet recruiting FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236036Phase 1 · active not recruiting Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778602early Phase 1 · not yet recruiting Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07788430NA · not yet recruiting Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039281Phase 1/Phase 2 · active not recruiting Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07076472early Phase 1 · recruiting Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07579208Phase 1 · recruiting A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170141Phase 1 · terminated Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214392Phase 1 · active not recruiting Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05096481Phase 2 · recruiting PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463848Phase 2 · active not recruiting Surgical Pembro +/- Olaparib w TMZ for rGBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954636recruiting Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07209241Phase 1 · active not recruiting Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07485049early Phase 1 · recruiting BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07775534NA · not yet recruiting Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02977780Phase 2 · recruiting INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06108206active not recruiting Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06556563Phase 3 · recruiting EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762716Phase 1/Phase 2 · not yet recruiting Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047264NA · recruiting Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04903795Phase 1 · recruiting BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319027Phase 2 · recruiting Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07767110Phase 1/Phase 2 · not yet recruiting Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Midline Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769918NA · not yet recruiting Hypoxia-targeted Radiotherapy Boost for GBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05095376Phase 3 · active not recruiting Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607407Phase 2 · suspended Methimazole in Patients With Progressive Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859334Phase 2 · active not recruiting Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | WHO Grade 4 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492486Phase 2 · recruiting Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06632236Phase 1 · active not recruiting 5G-EMERALD: Amivantamab in Malignant Brain Tumours · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Hemispheric Glioma, H3 G34-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894979Phase 1 · active not recruiting Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Childhood Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07091864NA · recruiting Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | WHO Grade 4 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06344130Phase 1 · recruiting Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03389802Phase 1 · completed Phase I Study of APX005M in Pediatric Central Nervous System Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05450744Phase 1 · active not recruiting 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476939Phase 3 · recruiting Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186401Phase 1 · recruiting Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06614855Phase 1 · active not recruiting A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052877recruiting The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244995NA · active not recruiting Mind-Body Intervention in Glioma Couples · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161519Phase 1/Phase 2 · recruiting PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544992Phase 1 · recruiting Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083512recruiting Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739372NA · completed Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544526Phase 1 · recruiting CAR T Cells to Target GD2 for DMG · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07100730Phase 3 · recruiting Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758062Phase 2 · not yet recruiting Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197934Phase 1 · active not recruiting WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469075Phase 2 · active not recruiting Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07074756NA · recruiting A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501559Phase 1/Phase 2 · recruiting A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07754734Phase 2 · not yet recruiting STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02455557Phase 2 · active not recruiting SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761070Phase 3 · completed Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173829recruiting A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733674Phase 1 · recruiting Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751744Phase 1/Phase 2 · not yet recruiting Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01837862Phase 1/Phase 2 · active not recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862430Phase 2 · active not recruiting A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730869NA · completed Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086497NA · recruiting WBSI Guided Personalized Delivery of TTFields · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565118Phase 1 · recruiting Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07003542Phase 2 · recruiting A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708352Phase 2 · recruiting A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07748299available NuvOx Expanded Access · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643549Phase 1/Phase 2 · recruiting Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680439Phase 2 · recruiting Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03868943Phase 2 · terminated Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04099797Phase 1 · recruiting C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06624371Phase 1 · recruiting Atovaquone Combined With Radiation in Children With Malignant Brain Tumors · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152982Phase 2/Phase 3 · active not recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06069726Phase 2 · recruiting A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07206849Phase 2 · not yet recruiting Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | WHO Grade 4 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739017Phase 1 · not yet recruiting OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297125active not recruiting Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598244Phase 1 · active not recruiting Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970447Phase 2/Phase 3 · recruiting A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04555577Phase 1 · active not recruiting Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05781321Phase 2 · active not recruiting Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991101Phase 2 · recruiting Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07464925Phase 1 · recruiting A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma · condition mapped ALIAS · 1,854 trials mapped (596 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735819Phase 2 · not yet recruiting Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05023551early Phase 1 · active not recruiting Study of DSP-0390 in Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05284643NA · recruiting Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208362Phase 1 · active not recruiting Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07731555NA · recruiting Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological Analyses · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01339052Phase 2 · completed Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879250Phase 2 · recruiting WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 1,854 trials mapped (596 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06973096Phase 1 · active not recruiting CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06672575Phase 1/Phase 2 · recruiting A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910306NA · recruiting Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02359565Phase 1 · active not recruiting Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04479696NA · recruiting Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900792Phase 1 · active not recruiting A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05278208Phase 1/Phase 2 · recruiting Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177964Phase 2 · recruiting Lerapolturev (PVSRIPO) in GBM · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715097Phase 2 · not yet recruiting Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02902757NA · completed FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma · condition mapped CURATED_BROADER · 1,854 trials mapped (596 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |